A prospective, observational study was conducted in six European countries over three consecutive RSV seasons (October 2021 until April 2024).

ECDC has launched a call for experts to join a new Scientific Expert Panel to support the development of technical guidance on RSV vaccination to protect adults. Applications must be submitted by 5 April 2026.

Adult obesity has been linked to specific infections, but evidence across the full spectrum of infectious diseases remains scarce.

In this self-controlled case series study of 11 887 patients, the risk of cardiorespiratory events after RSV-related hospitalization was significantly higher than during the control period.

Real-world evidence on nirsevimab impact beyond the first season when given under universal immunisation programmes is emerging.

The Society has published a Clinical Consensus Statement in the European Heart Journal highlighting the key role of vaccination in preventing cardiovascular events.

In partnership with ESWI, the Coalition for Life Course Immunisation has released a new policy brief highlighting the urgent need for a more coordinated, life-course approach to respiratory virus prevention across the EU.

Check out this Satellite Symposium organised by the ESWI IDC and supported by IFPMA and Sanofi from ESWI2026.